Microbion Corporation
3 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| Multi-center Study to Assess Safety, Tolerability and Efficacy of Topical Pravibismane in Moderate DFI Patients (NCT05174806) | Microbion Corporation | 2022-06-13 |
Track Microbion Corporation automatically
Every clearance here is in the API, with alerts when new ones post.